112 related articles for article (PubMed ID: 11106824)
1. Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients.
Lehrer S; McCurdy LD; Stock RG; Kornreich R; Stone NN; Eng C
Cancer Genet Cytogenet; 2000 Oct; 122(2):131-3. PubMed ID: 11106824
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) gene.
Lehrer S; Diamond EJ; Stone NN; Droller MJ; Stock RG; Stone M; Bajwa A; Kornreich R
Urol Oncol; 2003; 21(2):101-4. PubMed ID: 12856637
[TBL] [Abstract][Full Text] [Related]
3. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.
Drucker L; Shpilberg O; Neumann A; Shapira J; Stackievicz R; Beyth Y; Yarkoni S
Cancer; 2000 Feb; 88(4):755-60. PubMed ID: 10679643
[TBL] [Abstract][Full Text] [Related]
4. No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.
Abrahamson J; Moslehi R; Vesprini D; Karlan B; Fishman D; Smotkin D; Ben David Y; Biran H; Fields A; Brunet JS; Narod SA
Cancer Res; 1998 Jul; 58(14):2919-22. PubMed ID: 9679945
[TBL] [Abstract][Full Text] [Related]
5. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.
Petrukhin L; Dangel J; Vanderveer L; Costalas J; Bellacosa A; Grana G; Daly M; Godwin AK
Cancer Res; 1997 Dec; 57(24):5480-4. PubMed ID: 9407954
[TBL] [Abstract][Full Text] [Related]
6. The characterization of somatic APC mutations in colonic adenomas and carcinomas in Ashkenazi Jews with the APC I1307K variant using linkage disequilibrium.
Zauber NP; Sabbath-Solitare M; Marotta SP; Bishop DT
J Pathol; 2003 Feb; 199(2):146-51. PubMed ID: 12533826
[TBL] [Abstract][Full Text] [Related]
7. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
8. APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.
Stern HS; Viertelhausen S; Hunter AG; O'Rourke K; Cappelli M; Perras H; Serfas K; Blumenthall A; Dewar D; Baumann E; Lagarde AE
Gastroenterology; 2001 Feb; 120(2):392-400. PubMed ID: 11159880
[TBL] [Abstract][Full Text] [Related]
9. Somatic instability of the APC I1307K allele in colorectal neoplasia.
Gryfe R; Di Nicola N; Gallinger S; Redston M
Cancer Res; 1998 Sep; 58(18):4040-3. PubMed ID: 9751605
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps.
Syngal S; Schrag D; Falchuk M; Tung N; Farraye FA; Chung D; Wright M; Whetsell A; Miller G; Garber JE
JAMA; 2000 Aug; 284(7):857-60. PubMed ID: 10938175
[TBL] [Abstract][Full Text] [Related]
11. APC I1307K and the risk of prostate cancer.
Poynter JN; Cooney KA; Bonner JD; White KA; Tomsho LP; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):468-73. PubMed ID: 16537703
[TBL] [Abstract][Full Text] [Related]
12. Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.
Silverberg MS; Clelland C; Murphy JE; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Siminovitch KA
Hum Genet; 2001 Mar; 108(3):205-10. PubMed ID: 11354631
[TBL] [Abstract][Full Text] [Related]
13. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.
Boursi B; Sella T; Liberman E; Shapira S; David M; Kazanov D; Arber N; Kraus S
Eur J Cancer; 2013 Nov; 49(17):3680-5. PubMed ID: 23896379
[TBL] [Abstract][Full Text] [Related]
14. The I1307K polymorphism of the APC gene in colorectal cancer.
Prior TW; Chadwick RB; Papp AC; Arcot AN; Isa AM; Pearl DK; Stemmermann G; Percesepe A; Loukola A; Aaltonen LA; De La Chapelle A
Gastroenterology; 1999 Jan; 116(1):58-63. PubMed ID: 9869603
[TBL] [Abstract][Full Text] [Related]
15. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.
Locker GY; Kaul K; Weinberg DS; Gatalica Z; Gong G; Peterman A; Lynch J; Klatzco L; Olopade OI; Bomzer CA; Newlin A; Keenan E; Tajuddin M; Knezetic J; Coronel S; Lynch HT
Cancer Genet Cytogenet; 2006 Aug; 169(1):33-8. PubMed ID: 16875934
[TBL] [Abstract][Full Text] [Related]
16. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
Lehrer S; Fodor F; Stock RG; Stone NN; Eng C; Song HK; McGovern M
Br J Cancer; 1998 Sep; 78(6):771-3. PubMed ID: 9743298
[TBL] [Abstract][Full Text] [Related]
17. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
[TBL] [Abstract][Full Text] [Related]
18. Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect.
Rozen P; Naiman T; Strul H; Taussky P; Karminsky N; Shomrat R; Samuel Z; Yaron Y; Orr-Urtreger A
Cancer; 2002 May; 94(10):2561-8. PubMed ID: 12173321
[TBL] [Abstract][Full Text] [Related]
19. The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.
Bahar AY; Taylor PJ; Andrews L; Proos A; Burnett L; Tucker K; Friedlander M; Buckley MF
Cancer; 2001 Jul; 92(2):440-5. PubMed ID: 11466700
[TBL] [Abstract][Full Text] [Related]
20. Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim.
Niell BL; Long JC; Rennert G; Gruber SB
Am J Hum Genet; 2003 Dec; 73(6):1250-60. PubMed ID: 14624392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]